Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1999 2
2001 2
2002 2
2003 5
2004 2
2005 5
2006 2
2007 8
2008 7
2009 4
2010 8
2011 9
2012 6
2013 6
2014 4
2015 4
2016 2
2018 3
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21828114

74 results

Results by year

Filters applied: . Clear all
Page 1
Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.
Grgic A, Nestle U, Scheidhauer K, Puskas C, Ballek E, Hohloch K, Schubert J, König J, Pinkert J, Truemper L, Hellwig D, Kirsch CM. Grgic A, et al. Nuklearmedizin. 2011;50(1):39-47. doi: 10.3413/nukmed-0322-10-06. Epub 2010 Nov 8. Nuklearmedizin. 2011. PMID: 21057722
Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8-year follow-up data of 281 patients from the international RIT-registry.
Hohloch K, Windemuth-Kieselbach C, Kolz J, Zinzani PL, Cacchione R, Jurczak W, Bischof Delaloye A, Trümper L, Scholz CW. Hohloch K, et al. Br J Haematol. 2019 Mar;184(6):949-956. doi: 10.1111/bjh.15712. Epub 2018 Dec 4. Br J Haematol. 2019. PMID: 30515751 Free article.
Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma.
Derenzini E, Stefoni V, Maglie R, Casadei B, Pellegrini C, Broccoli A, Stefani G, Fanti S, Motta MR, Narducci R, Argnani L, Zinzani PL. Derenzini E, et al. Biol Blood Marrow Transplant. 2013 Dec;19(12):1695-701. doi: 10.1016/j.bbmt.2013.09.004. Epub 2013 Sep 18. Biol Blood Marrow Transplant. 2013. PMID: 24055654 Free article.
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
Witzig TE, Gordon LI, Cabanillas F, Czuczman MS, Emmanouilides C, Joyce R, Pohlman BL, Bartlett NL, Wiseman GA, Padre N, Grillo-López AJ, Multani P, White CA. Witzig TE, et al. J Clin Oncol. 2002 May 15;20(10):2453-63. doi: 10.1200/JCO.2002.11.076. J Clin Oncol. 2002. PMID: 12011122 Clinical Trial.
74 results